FWM
REGN icon

Filbrandt Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Filbrandt Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Buy
+4
New +$2.48K ﹤0.01% 190
2020
Q3 		– Sell
-1
Closed -$1K – 307
2020
Q2 		$1K Buy
+1
New +$568 ﹤0.01% 346

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Filbrandt Wealth Management's REGN Position: Q3 2021 in Review

Filbrandt Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2021: 4 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #190 among its holdings. This is a return to the name: Filbrandt Wealth Management previously reported a position in REGN as recently as Q2 2020.

Filbrandt Wealth Management first reported a position in REGN in Q2 2020 and has held it in 2 quarters since. 1,017 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • Filbrandt Wealth Management held 4 shares of Regeneron Pharmaceuticals worth $2K as of Q3 2021.
  • Regeneron Pharmaceuticals was a new Filbrandt Wealth Management position in Q3 2021.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #190 holding.
  • Filbrandt Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • 1,017 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.